Variant report
Variant | esv2753453 |
---|---|
Chromosome Location | chr2:113726882-113730425 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr2:113730015-113730296 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr2:113729870-113730644 | MCF10A-Er-Src | breast: | n/a | chr2:113730501-113730511 chr2:113730495-113730507 chr2:113730501-113730511 chr2:113730503-113730514 chr2:113730502-113730510 |
3 | FOS | chr2:113729883-113730489 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr2:113729851-113730726 | MCF10A-Er-Src | breast: | n/a | chr2:113730501-113730511 chr2:113730495-113730507 chr2:113730501-113730511 chr2:113730503-113730514 chr2:113730502-113730510 |
5 | FOS | chr2:113729921-113730646 | MCF10A-Er-Src | breast: | n/a | chr2:113730501-113730511 chr2:113730495-113730507 chr2:113730501-113730511 chr2:113730503-113730514 chr2:113730502-113730510 |
6 | MAFK | chr2:113726949-113727085 | HepG2 | liver: | n/a | chr2:113727015-113727030 |
7 | MYC | chr2:113729901-113730555 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | MYC | chr2:113729921-113730627 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr2:113727522-113727946 | H1-neurons | neurons: | n/a | n/a |
10 | POLR2A | chr2:113727459-113728008 | H1-neurons | neurons: | n/a | n/a |
11 | POLR2A | chr2:113729849-113730145 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr2:113729997-113730297 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr2:113729935-113730782 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr2:113729947-113730713 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | STAT3 | chr2:113730015-113730450 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:113719430..113721104-chr2:113727150..113729244,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IL36G-1 | chr2:113729437-113729596 | ucscGeneNc_uc002tjs_2 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IL36G | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17607787 | chr2:113726882-113726883 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs114472980 | chr2:113726897-113726898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371755546 | chr2:113726905-113726906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540073822 | chr2:113726908-113726909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112643571 | chr2:113726915-113726916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111908553 | chr2:113726926-113726927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567044323 | chr2:113726937-113726938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535968255 | chr2:113726943-113726944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555790030 | chr2:113726964-113726965 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs575551691 | chr2:113727015-113727016 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs142884562 | chr2:113727038-113727039 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs11897907 | chr2:113727061-113727062 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs576708087 | chr2:113727131-113727132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545619294 | chr2:113727165-113727166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146086039 | chr2:113727201-113727202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528233291 | chr2:113727217-113727218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537596256 | chr2:113727237-113727238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561820647 | chr2:113727259-113727260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182083364 | chr2:113727271-113727272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550535879 | chr2:113727368-113727369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571087230 | chr2:113727376-113727377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116676115 | chr2:113727466-113727467 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs547281558 | chr2:113727476-113727477 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs57933461 | chr2:113727507-113727508 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs10174484 | chr2:113727570-113727571 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs186852085 | chr2:113727572-113727573 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs79427700 | chr2:113727594-113727595 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs537883802 | chr2:113727598-113727599 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs143596847 | chr2:113727641-113727642 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs575197922 | chr2:113727685-113727686 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs577584841 | chr2:113727763-113727764 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs539362440 | chr2:113727861-113727862 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs376195020 | chr2:113727913-113727914 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs552803820 | chr2:113727918-113727919 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs572750675 | chr2:113727926-113727927 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs534189113 | chr2:113727965-113727966 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs181950378 | chr2:113727966-113727967 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs146775246 | chr2:113727983-113727984 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs540471619 | chr2:113729256-113729257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188422307 | chr2:113729312-113729313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75454753 | chr2:113729319-113729320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531600935 | chr2:113729345-113729346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552942301 | chr2:113729367-113729368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551882778 | chr2:113729386-113729387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138290123 | chr2:113729387-113729388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564889902 | chr2:113729443-113729444 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs533888165 | chr2:113729451-113729452 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs562172567 | chr2:113729469-113729470 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs192321742 | chr2:113729524-113729525 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs184855294 | chr2:113729534-113729535 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113726400-113727000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
2 | chr2:113726400-113727000 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
3 | chr2:113726400-113727200 | Enhancers | Primary T cells fromperipheralblood | blood |
4 | chr2:113726400-113727400 | Enhancers | Primary T cells from cord blood | blood |
5 | chr2:113726600-113727000 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr2:113726600-113727000 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
7 | chr2:113726600-113727000 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
8 | chr2:113726600-113727000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr2:113726600-113727200 | Enhancers | Fetal Thymus | thymus |
10 | chr2:113726600-113727400 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
11 | chr2:113729200-113731600 | Enhancers | HMEC | breast |
12 | chr2:113729400-113729600 | Enhancers | NHEK | skin |
13 | chr2:113729400-113731400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr2:113729600-113729800 | Flanking Active TSS | NHEK | skin |
15 | chr2:113729600-113731200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr2:113729600-113731200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr2:113729800-113730200 | Enhancers | NHEK | skin |
18 | chr2:113730200-113730600 | Flanking Active TSS | NHEK | skin |